Bouke de Jong

21PUBLICATIONS
83CO-AUTHORS
Microbial geneticsMedical virologyPreventative health careMedical infection agents (incl. prions)Virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 28, 2026
No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context.

|Mar 11, 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa.

Faridath Massou, Bassirou Diarra, Awa Ba Diallo

|Dec 02, 2025
Large-scale field application of a fingerstick blood test for Mycobacterium leprae infection: Monitoring population-wide effects of case finding and post-exposure prophylaxis on transmission in the Comoros and Madagascar.

Louise Pierneef, Sofie M Braet, Danielle de Jong

|Sep 22, 2025
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders

|Aug 12, 2025
Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.

Bertin C Bisimwa, Maja Kiselinova, Isabel Cuella-Martin

|Mar 22, 2025
Paucibacillary Tuberculosis Drives the Low Positive Predictive Value of Xpert MTB/RIF Ultra for Rifampicin Resistance Detection in Low-Prevalence Settings.

Isabel Cuella-Martin, Francois Hakizayezu, Aymen Ahmed

Pageof 4

Frequent Collaborators

6 joint publications

Leen Rigouts

5 joint publications

Tom Decroo

3 joint publications

Conor Joseph Meehan

3 joint publications

Wim Mulders